BioCentury
ARTICLE | Company News

AbGenomics, Boehringer Ingelheim deal

February 6, 2012 8:00 AM UTC

In December, AbGenomics said it will regain rights to AbGn-168H from Boehringer Ingelheim, effective Feb. 13. The companies mutually terminated the 2005 deal giving Boehringer exclusive, worldwide ri...